{
  "_metadata": {
    "version": "1.0.0",
    "last_updated": "2026-03-01",
    "sources": [
      "American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2023;71(7):2052-2081.",
      "By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel"
    ],
    "applicable_population": "Adults aged 65 years and older",
    "maintainer": "PGx Clinical Solutions"
  },
  "beers_criteria": [
    {
      "drug": "diphenhydramine",
      "drug_class": "first_generation_antihistamine",
      "category": "avoid",
      "rationale": "Highly anticholinergic; clearance reduced with advanced age. Tolerance develops when used as hypnotic. Risk of confusion, dry mouth, constipation, urinary retention.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["loratadine", "cetirizine", "fexofenadine"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "chlorpheniramine",
      "drug_class": "first_generation_antihistamine",
      "category": "avoid",
      "rationale": "Highly anticholinergic; clearance reduced with advanced age.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["loratadine", "cetirizine", "fexofenadine"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "hydroxyzine",
      "drug_class": "first_generation_antihistamine",
      "category": "avoid",
      "rationale": "Highly anticholinergic; clearance reduced with advanced age.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["loratadine", "cetirizine", "fexofenadine"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "promethazine",
      "drug_class": "first_generation_antihistamine",
      "category": "avoid",
      "rationale": "Highly anticholinergic; risk of sedation, confusion, falls.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["ondansetron"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "amitriptyline",
      "drug_class": "tertiary_tca",
      "category": "avoid",
      "rationale": "Highly anticholinergic, sedating, and causes orthostatic hypotension. Safety profile of low-dose TCAs for neuropathic pain is comparable to alternatives.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["duloxetine", "venlafaxine", "sertraline", "gabapentin"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "clomipramine",
      "drug_class": "tertiary_tca",
      "category": "avoid",
      "rationale": "Highly anticholinergic, sedating, and causes orthostatic hypotension.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["sertraline", "escitalopram", "duloxetine"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "doxepin",
      "drug_class": "tertiary_tca",
      "category": "avoid",
      "rationale": "Highly anticholinergic, sedating. Doses >6 mg/day not recommended in older adults.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["trazodone", "melatonin"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "imipramine",
      "drug_class": "tertiary_tca",
      "category": "avoid",
      "rationale": "Highly anticholinergic, sedating, and causes orthostatic hypotension.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["sertraline", "escitalopram"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "nortriptyline",
      "drug_class": "secondary_tca",
      "category": "avoid",
      "rationale": "Anticholinergic effects; risk of cardiac conduction disturbances. Less anticholinergic than tertiary TCAs but still concerning in elderly.",
      "severity": "moderate",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["duloxetine", "gabapentin", "pregabalin"],
      "conditions": [],
      "acb_score": 2
    },
    {
      "drug": "diazepam",
      "drug_class": "long_acting_benzodiazepine",
      "category": "avoid",
      "rationale": "Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents. Risk of cognitive impairment, delirium, falls, fractures.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["buspirone", "duloxetine", "trazodone"],
      "conditions": [],
      "acb_score": 1
    },
    {
      "drug": "clonazepam",
      "drug_class": "long_acting_benzodiazepine",
      "category": "avoid",
      "rationale": "Increased sensitivity to benzodiazepines in older adults. Risk of cognitive impairment, delirium, falls, fractures.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["buspirone", "duloxetine"],
      "conditions": [],
      "acb_score": 1
    },
    {
      "drug": "chlordiazepoxide",
      "drug_class": "long_acting_benzodiazepine",
      "category": "avoid",
      "rationale": "Long half-life in elderly; risk of prolonged sedation, falls, cognitive impairment.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["buspirone", "trazodone"],
      "conditions": [],
      "acb_score": 1
    },
    {
      "drug": "lorazepam",
      "drug_class": "short_acting_benzodiazepine",
      "category": "avoid",
      "rationale": "Older adults have increased sensitivity. Risk of cognitive impairment, delirium, falls, fractures. Should not exceed 3mg/day if used.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["buspirone", "trazodone"],
      "conditions": [],
      "acb_score": 1
    },
    {
      "drug": "alprazolam",
      "drug_class": "short_acting_benzodiazepine",
      "category": "avoid",
      "rationale": "Increased sensitivity to benzodiazepines in older adults. Risk of cognitive impairment, delirium, falls.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["buspirone", "duloxetine"],
      "conditions": [],
      "acb_score": 1
    },
    {
      "drug": "temazepam",
      "drug_class": "short_acting_benzodiazepine",
      "category": "avoid",
      "rationale": "Increased sensitivity. Risk of cognitive impairment, falls.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["melatonin", "trazodone"],
      "conditions": [],
      "acb_score": 1
    },
    {
      "drug": "zolpidem",
      "drug_class": "nonbenzodiazepine_hypnotic",
      "category": "avoid",
      "rationale": "Benzodiazepine receptor agonist with similar adverse events as benzodiazepines. Increased ER visits and hospitalizations. Minimal improvement in sleep latency and duration.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["melatonin", "trazodone", "sleep_hygiene"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "eszopiclone",
      "drug_class": "nonbenzodiazepine_hypnotic",
      "category": "avoid",
      "rationale": "Similar risks to benzodiazepines in older adults.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["melatonin", "trazodone", "sleep_hygiene"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "haloperidol",
      "drug_class": "conventional_antipsychotic",
      "category": "avoid",
      "rationale": "Increased risk of cerebrovascular accident (stroke) and greater rate of cognitive decline and mortality in persons with dementia. Avoid use for behavioral problems of dementia unless non-pharmacological options have failed and patient is threat to self or others.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["behavioral_interventions"],
      "conditions": ["dementia"],
      "acb_score": 1
    },
    {
      "drug": "quetiapine",
      "drug_class": "atypical_antipsychotic",
      "category": "avoid",
      "rationale": "Increased risk of stroke and mortality in persons with dementia. Highly sedating and anticholinergic.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["behavioral_interventions"],
      "conditions": ["dementia"],
      "acb_score": 3
    },
    {
      "drug": "olanzapine",
      "drug_class": "atypical_antipsychotic",
      "category": "avoid",
      "rationale": "Increased risk of stroke and mortality in persons with dementia. Anticholinergic. Metabolic effects.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["behavioral_interventions"],
      "conditions": ["dementia"],
      "acb_score": 2
    },
    {
      "drug": "oxybutynin",
      "drug_class": "anticholinergic_bladder",
      "category": "avoid",
      "rationale": "Strongly anticholinergic; cognitive adverse effects. Immediate-release forms particularly problematic. Extended-release or transdermal preferred if anticholinergic must be used.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["mirabegron", "behavioral_therapy"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "tolterodine",
      "drug_class": "anticholinergic_bladder",
      "category": "avoid",
      "rationale": "Anticholinergic adverse effects; cognitive impairment risk in elderly.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["mirabegron", "behavioral_therapy"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "solifenacin",
      "drug_class": "anticholinergic_bladder",
      "category": "avoid",
      "rationale": "Anticholinergic adverse effects in elderly.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["mirabegron", "behavioral_therapy"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "omeprazole",
      "drug_class": "proton_pump_inhibitor",
      "category": "caution",
      "rationale": "Risk of C. difficile infection, bone loss, and fractures with prolonged use (>8 weeks). Avoid scheduled use >8 weeks unless for high-risk patients.",
      "severity": "moderate",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["famotidine", "lifestyle_modifications"],
      "conditions": ["prolonged_use_over_8_weeks"],
      "acb_score": 0
    },
    {
      "drug": "pantoprazole",
      "drug_class": "proton_pump_inhibitor",
      "category": "caution",
      "rationale": "Risk of C. difficile, bone loss, fractures with prolonged use (>8 weeks).",
      "severity": "moderate",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["famotidine", "lifestyle_modifications"],
      "conditions": ["prolonged_use_over_8_weeks"],
      "acb_score": 0
    },
    {
      "drug": "lansoprazole",
      "drug_class": "proton_pump_inhibitor",
      "category": "caution",
      "rationale": "Risk of C. difficile, bone loss, fractures with prolonged use.",
      "severity": "moderate",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["famotidine", "lifestyle_modifications"],
      "conditions": ["prolonged_use_over_8_weeks"],
      "acb_score": 0
    },
    {
      "drug": "naproxen",
      "drug_class": "nsaid",
      "category": "avoid",
      "rationale": "Increased risk of GI bleeding/peptic ulcer disease, acute kidney injury, and fluid retention. Risk further increased with concurrent use of corticosteroids, anticoagulants, or antiplatelet agents.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["acetaminophen", "topical_nsaids", "duloxetine"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "ibuprofen",
      "drug_class": "nsaid",
      "category": "avoid",
      "rationale": "Increased risk of GI bleeding, acute kidney injury, fluid retention in older adults.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["acetaminophen", "topical_nsaids", "duloxetine"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "indomethacin",
      "drug_class": "nsaid",
      "category": "avoid",
      "rationale": "Highest risk of GI adverse effects among NSAIDs. Also CNS adverse effects.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["acetaminophen", "topical_nsaids"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "meloxicam",
      "drug_class": "nsaid",
      "category": "avoid",
      "rationale": "Increased risk of GI bleeding, acute kidney injury in elderly.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["acetaminophen", "topical_nsaids"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "glimepiride",
      "drug_class": "sulfonylurea",
      "category": "avoid",
      "rationale": "Higher risk of severe prolonged hypoglycemia in older adults.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["metformin", "linagliptin", "empagliflozin"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "glyburide",
      "drug_class": "sulfonylurea",
      "category": "avoid",
      "rationale": "Higher risk of severe prolonged hypoglycemia. Longest duration of action among sulfonylureas.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["metformin", "linagliptin", "empagliflozin"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "cyclobenzaprine",
      "drug_class": "skeletal_muscle_relaxant",
      "category": "avoid",
      "rationale": "Anticholinergic adverse effects, sedation, increased risk of fractures. Effectiveness at doses tolerated by older adults questionable.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["physical_therapy", "acetaminophen"],
      "conditions": [],
      "acb_score": 3
    },
    {
      "drug": "methocarbamol",
      "drug_class": "skeletal_muscle_relaxant",
      "category": "avoid",
      "rationale": "Sedation, increased risk of fractures in older adults.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["physical_therapy", "acetaminophen"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "metaxalone",
      "drug_class": "skeletal_muscle_relaxant",
      "category": "avoid",
      "rationale": "Sedation, increased risk of fractures. Poorly tolerated by older adults.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["physical_therapy", "acetaminophen"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "doxazosin",
      "drug_class": "alpha1_blocker",
      "category": "avoid",
      "rationale": "High risk of orthostatic hypotension. Not recommended as routine treatment for hypertension. Alternative agents have superior risk/benefit profile.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["tamsulosin", "finasteride"],
      "conditions": ["hypertension"],
      "acb_score": 0
    },
    {
      "drug": "prazosin",
      "drug_class": "alpha1_blocker",
      "category": "avoid",
      "rationale": "High risk of orthostatic hypotension in elderly.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["tamsulosin"],
      "conditions": ["hypertension"],
      "acb_score": 0
    },
    {
      "drug": "clonidine",
      "drug_class": "central_alpha_agonist",
      "category": "avoid",
      "rationale": "High risk of CNS adverse effects. Risk of bradycardia and orthostatic hypotension. Not recommended as routine treatment for hypertension.",
      "severity": "high",
      "quality_of_evidence": "low",
      "strength_of_recommendation": "strong",
      "alternatives": ["amlodipine", "lisinopril"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "methyldopa",
      "drug_class": "central_alpha_agonist",
      "category": "avoid",
      "rationale": "High risk of CNS adverse effects including bradycardia. May exacerbate depression.",
      "severity": "high",
      "quality_of_evidence": "low",
      "strength_of_recommendation": "strong",
      "alternatives": ["amlodipine", "lisinopril"],
      "conditions": [],
      "acb_score": 2
    },
    {
      "drug": "digoxin",
      "drug_class": "cardiac_glycoside",
      "category": "caution",
      "rationale": "Decreased renal clearance may lead to toxicity. Should not exceed 0.125 mg/day except for atrial fibrillation. Toxic levels associated with anorexia, nausea, visual changes, cardiac arrhythmias.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["rate_control_alternatives"],
      "conditions": ["max_dose_0.125mg"],
      "acb_score": 0
    },
    {
      "drug": "meperidine",
      "drug_class": "opioid_analgesic",
      "category": "avoid",
      "rationale": "Not an effective oral analgesic at commonly used doses. Neurotoxic metabolite normeperidine accumulates with renal impairment. Risk of seizures.",
      "severity": "high",
      "quality_of_evidence": "high",
      "strength_of_recommendation": "strong",
      "alternatives": ["morphine", "hydromorphone", "acetaminophen"],
      "conditions": [],
      "acb_score": 2
    },
    {
      "drug": "nitrofurantoin",
      "drug_class": "urinary_anti_infective",
      "category": "avoid",
      "rationale": "Potential for pulmonary toxicity, hepatotoxicity, peripheral neuropathy. Avoid in patients with CrCl <30 mL/min due to inadequate drug concentration and toxicity risk.",
      "severity": "moderate",
      "quality_of_evidence": "low",
      "strength_of_recommendation": "strong",
      "alternatives": ["trimethoprim_sulfamethoxazole", "fosfomycin"],
      "conditions": ["creatinine_clearance_below_30"],
      "acb_score": 0
    },
    {
      "drug": "sliding_scale_insulin",
      "drug_class": "insulin_regimen",
      "category": "avoid",
      "rationale": "Higher risk of hypoglycemia without improvement in hyperglycemia management. Refers to insulin regimen only, not insulin itself.",
      "severity": "high",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["basal_insulin", "basal_bolus_regimen"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "mineral_oil",
      "drug_class": "laxative",
      "category": "avoid",
      "rationale": "Potential for aspiration and adverse effects. Safer alternatives available.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["polyethylene_glycol", "docusate", "senna"],
      "conditions": [],
      "acb_score": 0
    },
    {
      "drug": "trimethobenzamide",
      "drug_class": "antiemetic",
      "category": "avoid",
      "rationale": "One of the least effective antiemetics; can cause extrapyramidal adverse effects.",
      "severity": "moderate",
      "quality_of_evidence": "moderate",
      "strength_of_recommendation": "strong",
      "alternatives": ["ondansetron"],
      "conditions": [],
      "acb_score": 0
    }
  ]
}